Amplifying the efficacy of ALA-based prodrugs for photodynamic therapy using nanotechnology
5-aminolevulinic acid (ALA) is a clinically approved prodrug involved in intracellular Heme biosynthesis to produce the natural photosensitizer (PS) Protoporphyrin IX (PpIX). ALA based photodynamic therapy (PDT) has been used to treat various malignant and non-malignant diseases. However, natural AL...
Saved in:
Main Authors: | Liang Lou (Author), Shizhe Zhou (Author), Sijia Tan (Author), Menghua Xiang (Author), Wei Wang (Author), Chuang Yuan (Author), Liqian Gao (Author), Qicai Xiao (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Editorial: Prodrug design and therapeutic applications
by: Qicai Xiao, et al.
Published: (2023) -
Dexibuprofen Therapeutic Advances: Prodrugs and Nanotechnological Formulations
by: Anna Gliszczyńska, et al.
Published: (2021) -
Dual-responsive nanoparticles with transformable shape and reversible charge for amplified chemo-photodynamic therapy of breast cancer
by: Wenfeng Jia, et al.
Published: (2022) -
The application of ALA photodynamic fluorescence combined with dermatoscopy in the diagnosis of facial cancerization
by: XIA Liye, et al.
Published: (2024) -
Conjugation, Prodrug, and Co-Administration Strategies in Support of Nanotechnologies to Improve the Therapeutic Efficacy of Phytochemicals in the Central Nervous System
by: Giovanna Rassu, et al.
Published: (2023)